KEEP is designed to meet the unique challenges faced by patients taking subcutaneous dosing in the home – away from the guardrails of a clinic or traditional infusion center. In tandem, KEEP supports new product launches for pharma capturing early, rich, RWE and supporting proper outcomes.
passively capture dosing events
real time insights for manufacturers and health system partners
Key Challenge:
Uncontrolled environments, and blind to the patient journey post Rx
KEEP’s Solution:
Safeguard patient outcomes in the home with support systems for injection, while uncovering real world experience insights
Key Challenge:
Ensuring short and long term success of new patient starts
KEEP’s Solution:
KEEP provides a lens to the medication experience in the home, identifying leading indicators to therapy discontinuation, and catalyst to salvage strategies
Key Challenge:
Establish early adoption and trust with prescribers
KEEP’s Solution:
Create an engagement point with KOL by building an RWE moat through monitoring, measuring and publishing real-world experience of Keytruda post -launch
While real-world data captures how patients take their medication, KEEP goes beyond that with Real World Experience (RWE-X). RWE-X captures the true, human experience of living with specialty medications, giving pharma companies insights into how patients navigate their day-to-day lives with their treatment. This deeper understanding allows healthcare providers to offer more personalized and timely support, ultimately improving outcomes and patient satisfaction.
Pilot Phase
In the initial pilot phase, KEEP will be deployed to a select group of patients on Keytruda to demonstrate its impact on adherence and patient engagement.
Evaluation & Scaling
Following the pilot, we’ll assess the results and work with your team to fine-tune KEEP’s features to ensure maximum benefit for all patients on Keytruda.
Full-Scale Rollout
Once the pilot is complete, KEEP will be rolled out across all Keytruda patients, helping you deliver improved adherence and engagement at scale.
